Stockreport

Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update

Grace Therapeutics, Inc.  (GRCE) 
PDF Announced U.S. Food and Drug Administration (FDA) Acceptance for Reviewof New Drug Application (NDA) for GTx-104 FDA Established April 23, 2026 as PDUFA Target Date for [Read more]